JW Pharmaceutical Corporation (KRX: 001060)
South Korea
· Delayed Price · Currency is KRW
23,900
+400 (1.70%)
Nov 15, 2024, 3:30 PM KST
JW Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 35,653 | 37,006 | 31,892 | -967.85 | -15,241 | -25,275 | Upgrade
|
Depreciation & Amortization | 19,371 | 22,575 | 16,836 | 16,112 | 20,688 | 20,349 | Upgrade
|
Loss (Gain) From Sale of Assets | 23.96 | 1,088 | -3.28 | 1,048 | 12.24 | -18.15 | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | 4,821 | - | - | 85 | Upgrade
|
Loss (Gain) From Sale of Investments | -2,904 | -2,830 | 8,515 | 1,820 | - | - | Upgrade
|
Loss (Gain) on Equity Investments | -2,298 | -621.06 | 1,349 | 1,149 | 1,924 | 369.17 | Upgrade
|
Provision & Write-off of Bad Debts | -5,774 | -3,644 | 8,437 | 12,073 | 6,870 | 7,336 | Upgrade
|
Other Operating Activities | 56,429 | 53,846 | -8,913 | 32,946 | 13,584 | -10,227 | Upgrade
|
Change in Accounts Receivable | -2,832 | -4,734 | -4,312 | -41,566 | 45,208 | 37,302 | Upgrade
|
Change in Inventory | 4,992 | 8,917 | -11,541 | -2,655 | -8,876 | 19,784 | Upgrade
|
Change in Accounts Payable | 26,500 | -9,536 | 31,652 | 3,730 | 2,831 | -632.93 | Upgrade
|
Change in Unearned Revenue | -0 | -153.66 | -53.5 | - | -199.22 | -796.89 | Upgrade
|
Change in Other Net Operating Assets | -8,964 | -14,756 | -21,915 | -5,564 | -3,747 | 7,256 | Upgrade
|
Operating Cash Flow | 120,197 | 87,157 | 56,764 | 18,124 | 63,054 | 55,531 | Upgrade
|
Operating Cash Flow Growth | 106.03% | 53.54% | 213.20% | -71.26% | 13.55% | 6.57% | Upgrade
|
Capital Expenditures | -14,254 | -27,286 | -9,919 | -7,467 | -12,387 | -9,285 | Upgrade
|
Sale of Property, Plant & Equipment | 54.49 | 24.97 | 6.26 | 63,446 | 65.58 | 62.71 | Upgrade
|
Cash Acquisitions | -164.96 | -12,005 | -40.88 | - | - | -4,224 | Upgrade
|
Divestitures | - | - | - | 384.96 | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -14,299 | -13,419 | -2,433 | -5,435 | -2,652 | -3,892 | Upgrade
|
Investment in Securities | 2,036 | 8,260 | -26,344 | 1,078 | -61,955 | -1,125 | Upgrade
|
Other Investing Activities | 4,026 | -6,355 | 267.37 | -44,541 | 501.19 | -49.68 | Upgrade
|
Investing Cash Flow | -15,502 | -63,780 | -18,919 | -22,869 | -79,427 | -21,984 | Upgrade
|
Short-Term Debt Issued | - | 227,876 | 110,896 | 75,323 | 94,683 | 148,575 | Upgrade
|
Long-Term Debt Issued | - | 60,166 | 29,585 | 60,296 | 70,000 | 20,000 | Upgrade
|
Total Debt Issued | 213,531 | 288,042 | 140,481 | 135,619 | 164,683 | 168,575 | Upgrade
|
Short-Term Debt Repaid | - | -316,108 | -177,004 | -84,408 | -142,087 | -142,875 | Upgrade
|
Long-Term Debt Repaid | - | -4,051 | -2,795 | -16,845 | -29,427 | -17,810 | Upgrade
|
Total Debt Repaid | -290,873 | -320,159 | -179,799 | -101,254 | -171,515 | -160,685 | Upgrade
|
Net Debt Issued (Repaid) | -77,342 | -32,117 | -39,318 | 34,365 | -6,831 | 7,891 | Upgrade
|
Issuance of Common Stock | - | - | 10,000 | 398.47 | - | - | Upgrade
|
Repurchase of Common Stock | -332.45 | -260.88 | -281.6 | -412.29 | -224.25 | -258.46 | Upgrade
|
Common Dividends Paid | -9,665 | -8,814 | -7,352 | -7,149 | -6,954 | -6,816 | Upgrade
|
Other Financing Activities | -0 | -54 | 44 | -0 | - | -24,977 | Upgrade
|
Financing Cash Flow | -87,340 | -41,245 | -36,907 | 27,202 | -14,009 | -24,160 | Upgrade
|
Foreign Exchange Rate Adjustments | 11.55 | -120.69 | -406.38 | 458.72 | -1,031 | 1,529 | Upgrade
|
Miscellaneous Cash Flow Adjustments | 0 | 0 | - | - | - | - | Upgrade
|
Net Cash Flow | 17,368 | -17,989 | 531.45 | 22,915 | -31,413 | 10,916 | Upgrade
|
Free Cash Flow | 105,944 | 59,871 | 46,845 | 10,657 | 50,667 | 46,246 | Upgrade
|
Free Cash Flow Growth | 189.64% | 27.81% | 339.56% | -78.97% | 9.56% | 6.38% | Upgrade
|
Free Cash Flow Margin | 14.28% | 8.00% | 6.85% | 1.76% | 9.26% | 9.04% | Upgrade
|
Free Cash Flow Per Share | 4541.21 | 2565.56 | 2016.97 | 459.20 | 2182.01 | 1992.45 | Upgrade
|
Cash Interest Paid | 9,950 | 11,119 | 9,035 | 7,567 | 7,640 | 10,970 | Upgrade
|
Cash Income Tax Paid | 15,906 | 13,335 | 31,621 | 863.42 | -1,417 | 5,463 | Upgrade
|
Levered Free Cash Flow | 102,627 | 23,381 | 74,265 | -6,672 | 54,565 | 59,773 | Upgrade
|
Unlevered Free Cash Flow | 109,782 | 31,232 | 80,132 | -2,087 | 59,307 | 66,822 | Upgrade
|
Change in Net Working Capital | -60,745 | 11,032 | -37,842 | 24,577 | -54,485 | -71,534 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.